BD Medical Wins Ram Charan Management Practice Award for Leadership Development and Localization Strategy

Outstanding Entrepreneur Deng Jianmin Discusses Localized Talent Cultivation, Empowering Business Growth with Innovative Driving Force

ShanghaiOctober 31, 2023PR Newswire -- At the China Annual Meeting celebrating the 100th anniversary of the founding of Harvard Business Review on October 27, Deng Jianmin, Global Senior Vice President of BD and General Manager of Greater China, won the 2023 Ram Charan Management Practice Award for Excellence. The award was given in recognition of Deng Jianmin's leadership in the award-winning case "Finding Balance Between Stability and Flexibility – The Path to Leadership Reinvention for BD China’s Mid-to-Senior Management." This honors Mr. Deng Jianmin's foresight, creativity, and transformative impact in talent cultivation and development at BD Medical.

Deng Jianmin, Global Senior Vice President of BD and General Manager of Greater China, stated: "Talent is one of the driving forces behind BD's innovation in China and a significant competitive advantage. I am honored to receive this award, which is a great recognition of BD's talent development and innovation. We also hope to empower business growth by enabling localized talent and leadership breakthroughs, thereby fostering innovation."

The Ram Charan Management Practice Award, initiated by the Chinese edition of Harvard Business Review in collaboration with world-renowned management consultant Ram Charan, is a non-profit management award. It represents the highest honor in Chinese management practices, aiming to recognize enterprises and executives who have made innovative and referential contributions to management practices in China. The award also serves as a platform for Chinese companies to learn from practical management experiences.

The "BAP-Business Acceleration Program" submitted by BD this time is a talent development program aimed at middle-level core leaders. This program closely aligns with the company's 2025 business strategy, focusing on growth, empowerment, and simplification. It integrates professorial resources from multiple top universities and ecosystem collaborations, delivering practical content through five modules, ranging from strategic corporate finance to business simulation. The program cultivates talents capable of addressing future business challenges, fully meeting the needs of different levels.

Deng Jianmin stated: "In the face of the opportunities and challenges confronting the healthcare industry in an era of great transformation, the breakthroughs and shifts of leaders are crucial factors that profoundly impact organizational development. The mainstream 'professional manager-style' leaders in the healthcare sector urgently need to transition into leaders with greater foresight, creativity, and transformative power—balancing stability and flexibility while embodying resilience, forward-thinking, agility, openness, and empathy."

During the more than ten years that Deng Jianmin has served as Global Senior Vice President of BD and General Manager of Greater China, BD has adhered to the strategy of "In China, For China" and established a complete value chain system in China. This system covers the entire operational process from R&D, manufacturing, supply chain, marketing, sales to after-sales services. Gradually, BD has formed a business ecosystem centered around itself, continuously deepening its localization strategy in China, especially in "talent localization." BD aims to further empower local talents by enhancing their professional skills and leadership capabilities, while simultaneously promoting the high-quality development of China's healthcare industry.

In addition to BAP, BD has tailored hierarchical leadership development programs for managers at different levels. These include the "GMGM General Manager Mentoring Leadership Development Program" designed for senior leaders and the "LAP - Leadership Acceleration Program for Senior Managers" aimed at frontline senior sales and functional managers. These initiatives help construct clear leadership growth pathways for managers at all levels, supporting BD's rapid business growth while building a strong reserve of leadership talent to drive industry transformation.

Beyond the reshaping and upgrading of leadership, BD Medical consistently regards the development and cultivation of talent as a crucial pillar for achieving corporate strategy implementation. In Deng Jianmin's view, when a company prioritizes the creation of multidisciplinary talent training, the initiative of individuals will quickly generate an overflow effect. This strategy of integrating personal growth with company growth not only enhances the company’s soft competitiveness and attracts more high-quality talent but also plays a positive role in improving the overall talent level within the industry and driving the industry’s overall progress.

BD has always adhered to the mission of "advancing world health" and remained committed to being "patient-centered," striving to address some of the most challenging and urgent healthcare needs worldwide. As a pioneer in numerous groundbreaking medical technologies and devices, BD continuously drives innovation with technology at its core, focusing on meeting patients' needs through continuous advancements. Over nearly 30 years of development in China, BD has consistently strengthened its efforts in local talent cultivation and infrastructure, firmly establishing itself in the local market while promoting innovation and sustainable development. Moving forward, BD will continue to actively build an innovative platform and bridge within the global medical technology industry, empower the construction of a localized healthcare ecosystem in China, and promote the development of local talent. With the vision of "rooted in China, reaching the world," BD will continue to lead innovation progress in both China’s and the global healthcare industries.。